{"id":47052,"date":"2025-04-15T12:52:14","date_gmt":"2025-04-15T16:52:14","guid":{"rendered":"https:\/\/www.vielight.com\/?p=47052"},"modified":"2025-07-25T16:55:23","modified_gmt":"2025-07-25T20:55:23","slug":"neuro-optometric-tbi-lecture-vielight-tpbm-technology-dr-fitzgerald-and-dr-shidlofsky","status":"publish","type":"post","link":"https:\/\/www.vielight.com\/blog\/neuro-optometric-tbi-lecture-vielight-tpbm-technology-dr-fitzgerald-and-dr-shidlofsky\/","title":{"rendered":"Neuro-Optometric TBI Lecture | Vielight (tPBM) Technology | Dr Fitzgerald and Dr. Shidlofsky"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1144px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><h2>Introduction<\/h2>\n<p>Concussions, traumatic brain injuries (TBI), and neurodegenerative conditions present ongoing challenges in neurorehabilitation. During a recent lecture delivered by leading neuro-optometrists Dr. Charles Shidlofsky and Dr. DeAnn Fitzgerald, attendees were introduced to a novel adjunctive modality in neurorehabilitation: the Vielight Neuro, a non-invasive photobiomodulation (PBM) technology designed to deliver near-infrared (NIR) light to the brain.<\/p>\n<h2>Why Recovery Outcomes Differ: A Clinical Observation<\/h2>\n<p>Dr. Fitzgerald posed a critical question during her lecture: why do individuals with similar brain injuries often experience vastly different recovery outcomes? She pointed to neuroinflammation, mitochondrial dysfunction, and autonomic dysregulation as key variables. Without addressing these foundational issues, traditional rehabilitation efforts\u2014such as vision therapy, vestibular rehabilitation, and cognitive retraining\u2014may be less effective.<\/p>\n<\/div><div class=\"fusion-video fusion-youtube\" style=\"--awb-max-width:1920px;--awb-max-height:1080px;\"><div class=\"video-shortcode\"><lite-youtube videoid=\"nD8Q4J3-yNo\" class=\"landscape\" params=\"wmode=transparent&autoplay=1&enablejsapi=1\" title=\"YouTube video player 1\" width=\"1920\" height=\"1080\" data-thumbnail-size=\"auto\" data-no-cookie=\"off\"><\/lite-youtube><\/div><\/div><div class=\"fusion-text fusion-text-2\"><h2>The Vielight Neuro: A Tool to Support Neuroplasticity<\/h2>\n<p>With her many years of clinical work with the Vielight Neuro, Dr. Fitzgerald proposes the Vielight Neuro as a tool to reach cortical regions and interact with mitochondria, due to its optimal irradiance and 810nm NIR wavelength.<\/p>\n<p>Scientific and clinical observations presented in the lecture highlighted several PBM-supported processes:<\/p>\n<ul data-spread=\"false\">\n<li><strong>ATP Production<\/strong>: Enhanced mitochondrial output for increased cellular energy.<\/li>\n<li><strong>Anti-inflammatory Action<\/strong>: Downregulation of neuroinflammation.<\/li>\n<li><strong>Neuroplasticity Support<\/strong>: Activation of brain-derived neurotrophic factors (BDNF) and synaptic remodeling.<\/li>\n<li><strong>Autonomic Regulation<\/strong>: Shifting from sympathetic dominance to parasympathetic balance, supported by vagus nerve stimulation.<\/li>\n<\/ul>\n<h2>Lecture Case Examples: Application in Clinical Settings<\/h2>\n<p>The presenters shared a number of anonymized case observations. In concussion management, application of the Vielight Neuro device prior to or during neuro-vision therapy sessions appeared to correlate with:<\/p>\n<ul data-spread=\"false\">\n<li>Reduced headache frequency and photophobia within weeks<\/li>\n<li>Improvements in reaction time and cognitive performance<\/li>\n<li>Enhanced readiness for traditional therapies like eye tracking and balance training<\/li>\n<\/ul>\n<p>In one Parkinson\u2019s case, 12 weeks of structured PBM exposure coincided with:<\/p>\n<ul data-spread=\"false\">\n<li>Improved contrast sensitivity<\/li>\n<li>Enhanced gait and balance<\/li>\n<li>Reduced cognitive fatigue<\/li>\n<\/ul>\n<p>While causality cannot be confirmed, these observational insights supported further exploration.<\/p>\n<h2>Scientific Insights from Dr. Lew Lim<\/h2>\n<p>Dr. Lew Lim, founder of Vielight, expanded on the underlying science. He referenced functional MRI studies conducted at Baycrest Hospital (University of Toronto) with a new Vielight laser apparatus, in which intranasal and transcranial brain stimulation demonstrated measurable brain-wide responses:<\/p>\n<ul data-spread=\"false\">\n<li>At <strong>150 mW\/cm\u00b2 transcranial<\/strong>, blood-oxygen-level-dependent (BOLD) imaging showed increases in cerebral blood flow and activation.<\/li>\n<li>Optimal results were observed at <strong>10 Hz (alpha)<\/strong> and <strong>40 Hz (gamma)<\/strong> pulse frequencies.<\/li>\n<\/ul>\n<p>These findings align with earlier data from studies with the Vielight Neuro at the University of Utah and Brigham Young University, which tracked improvements in balance, reaction time, and mood in athletes exposed to repetitive head impacts.<\/p>\n<p>PBM via the Vielight Neuro is theorized to act through:<\/p>\n<ul data-spread=\"false\">\n<li><strong>Nitric oxide release<\/strong>, enabling vasodilation and perfusion<\/li>\n<li><strong>ATP synthesis<\/strong> for cellular energy<\/li>\n<li><strong>Activation of transcription factors<\/strong> such as NF-kB and Nrf2<\/li>\n<li><strong>Support of mitochondrial efficiency<\/strong> and reduction of oxidative stress<\/li>\n<\/ul>\n<h2>Potential Applications Discussed<\/h2>\n<p>The speakers emphasized the need for further study but highlighted areas under active investigation, including:<\/p>\n<ul data-spread=\"false\">\n<li>Visual Snow Syndrome<\/li>\n<li>Long COVID-related brain fog<\/li>\n<li>Stroke-related visual field issues<\/li>\n<li>Neurodegenerative conditions such as Parkinson\u2019s and mild cognitive impairment<\/li>\n<\/ul>\n<h2>Device Use: In-Clinic and at Home<\/h2>\n<p>Due to the device\u2019s sensitive construction, most use occurs in-clinic. However, practitioners noted that patients are increasingly purchasing the Vielight Neuro Duo for home use under clinical guidance. Additionally, the Vielight Vagus device\u2014targeting the vagus nerve\u2014was discussed for its role in supporting parasympathetic activity and sleep regulation.<\/p>\n<h2>Conclusion: A New Frontier in Brain Stimulation<\/h2>\n<p>This lecture reinforced that photobiomodulation via the Vielight Neuro is an emerging area of interest in neurorehabilitation. By potentially influencing key pathways related to energy production, inflammation, and brain network reorganization, the technology offers new avenues for enhancing resilience and recovery.<\/p>\n<p>As the field advances through more rigorous research and clinical trials, including studies aiming for FDA clearance, the Vielight Neuro may continue to gain traction as a tool for supporting neurological function across a range of applications.<\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":48044,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"bwfblock_default_font":"","inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[2977,2741,3014,1031,900],"tags":[],"class_list":["post-47052","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-brain-stimulation","category-intranasal-photobiomodulation","category-neurotechnology","category-transcranial-photobiomodulation","category-traumatic-brain-injury"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/posts\/47052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/comments?post=47052"}],"version-history":[{"count":0,"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/posts\/47052\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/media\/48044"}],"wp:attachment":[{"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/media?parent=47052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/categories?post=47052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vielight.com\/wp-json\/wp\/v2\/tags?post=47052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}